BIO-Europe 2022 | Informa Connect | 1 November 2022 | Virtual Event

Register today and find your next partner at the industry's largest gathering of biopharma professionals in Europe.

Promote your participation at the event - browse the library of assets available for you to make the most out of BIO-Europe.

In the heart of Europe, Leipzig is the epicenter for life science sector. Learn all of what this city has to offer you this BIO-Europe 2022.

This year we are back face-to-face! Leave no stone unturned through the numerous networking opportunities we have planned for you.

In keeping with our sustainability initiatives, we highly encourage you to make use of the different means of public transportation during BIO-Europe to get to and from the conference center and other various locations.

Our must-attend global partnering event provides you with easy access to the Global Biopharma community—all under one roof.

Boost your business development skills before attending BIO-Europe in this long-running course which offers lectures from experienced dealmakers, reviews of example models, dissections of actual deals, interaction with other participants, and live Q&A.

2022 Speakers

Khatereh Ahmadi
Head of Search and Evaluation Business Development, Europe and Middle East, MSD

Hiroyuki Akatsuka
Associate Director, Life Sciences Industry Division, Osaka Prefectural Government

Christopher Aleong
Managing Director, North America & Head of Global Licensing, BioEngine Technology Development Inc.

Isabel Antholz
Managing Director, Mannin GmbH

Daniela Begolo
Principal, Inkef

Sascha Berger
Partner, TVM Capital

Fabian Berkemeier
Director, Value & Access Strategy, IGES Institut

Hubert Birner
Managing Partner, TVM Life Science Management Inc.

Ulrica Slåne Bjerke
Founder and CIO, Arctic Aurora Life Science

Ezio Bonifacio
Professor, CRTD, TU Dresden

Julia Busch-Casler
Head of the Digital Health, Fraunhofer IMW

Rebecca Canter
Senior Director - Venture Sciences Europe, Eli Lilly & Co

Ruth Ciesinger
Online Managing Editor, der Tagesspiegel

Ashley Cox
Senior Principal, Head of Europe, EVERSANA Management Consultancy

Andrew Crockford
Director, Early Innovation Partnering - Oncology (EMEA), Johnson & Johnson Innovation

Chad Davis
Partner, Dechert LLP

Erin Denny
Head of Oncology Search & Evaluation, Business Development, Amgen

Florian Diwischek
Head HE&OR, Novartis

Dr. John Easton
Board Advisor, Sterling Technology

Duncan Emerton
Executive Director, Consulting, Citeline

Kerem Erden
Vice President and Head of Collaborate2Cure Hub EMEA, Bayer AG

Elena Fernandez- Kleinlein
Head of JLabs EMEA, Johnson & Johnson Innovation

Susanne Fiedler
Chief Commercial Officer, Organon

Anke Fuchs
Research Group Leader, Center for Regenerative Therapies Dresden (CRTD)

Norman Gerstner
CEO, Biotype GmbH

Yuri (Jurijus) Gleba
CEO, Nomad Bioscience GmbH

Uli Grabenwarter
Head of Venture, EIF

Anton Gueth
Managing Director, EVOLUTION Life Science Partners

John Haurum
Board Member, DJS Antibodies

Andre Hofmann
CEO, biosaxony e.V.

Peter Homberg
Lawyer, Dentons LLP

Dmitrij Hristodorov
Partner, Forbion

Nouhad Husseini
Vice President, Business Development, Regeneron Pharmaceuticals, Inc.

Friedemann Janus
Senior VP, Head of Business Development & Licensing, Open Innovation and Divestitures, Bayer AG, Berlin, Germany

Christian Jung
Partner, SV Health Investors

Nicola Kidman
Principal Consultant - Regulatory Affairs, Arriello

Karin Kleinhans
Partner, MRLV

Victor Klimyuk
Managing Director/COO, Icon Genetics GmbH

Olaf Koenig
Executive Director, Amgen

Matthias Kromayer
Managing Partner, MIG AG

Ulrike Köhl
Director, Fraunhofer Institut für Zelltherapie und Immunologie (IZI)

Jenny Laird
VP, Search & Evaluation Neuroscience, Eli Lilly and Company

Laura Lane
Vice President Venture Science (Head of Europe), Eli Lilly & Co. Ltd.

Werner Lanthaler
CEO, Evotec

Peng Leong
Chief Business Officer & Head of Brain Aging, BioAge Labs

Stephanie Leouzon
Partner and Head of Torreya Europe, Torreya

Olivier Litzka
Partner, Edmond de Rothschild Investment Partners

Peter Llewellyn-Davies
President, Biotech Austria

Philippe Lopes-Fernandes
Executive Vice President and Chief Business Officer, IPSEN

Andrew Mackie
Chief Business Officer, Imcyse

Roman Mathaes
Head of Pharmaceutical Services, Lonza

Detlev Mennerich
SVP, heading Global BD&L, Boehringer Ingelheim

Marianne Mertens
Partner, Apollo Health Ventures

Laura Millichamp
Founder, InsideReg

Shardha Millington
Consultant, Citeline (Formerly Pharma Intelligence)

Faical Miyara
Head of Global Partnering, Oncology, Ipsen

Bernd Muehlenweg
Senior Vice President Global Business Development, Evotec

Matthias Muellenbeck
SVP, Head of Global Business Development & Alliance Management, Merck Group

Marlis Müllner
Director R&D Investment, Austrian Business Agency

Barbara Natke
Vice President, Business Development, AVEO Oncology

Panu Noppari
Formulation Scientist, Nanoform

Hugh Nuthall
Senior Director, Search & Evaluate, Eli Lilly & Co. Ltd.

Kieran O'Donnell
VP Global Drug Safety, Arriello

Stephanie Oestreich
Chief Business Officer, Galecto Biotech

Linda Pullan
Founder, Pullan Consulting

Holger Reithinger
Partner, Forbion

Toby Richardson
Senior Director, Early Innovation Partnering Immunology, Johnson & Johnson Innovation EMEA

Anna Rivkin
VP, Business Development for Cardiovascular, Fibrosis, Immunology & Neuroscience, BMS

Christian Rommel
Head of PH Research & Development, Bayer AG

Vishal Sahni
Director, Corporate Business Development & Strategy, H. Lundbeck A/S

Zaki Salanti
Senior Director, Head of Search & Evaluation, Novo Nordisk A/S

Isabelle Scarabin
Director, Business Development & Licensing Officer, Bayer

Stephan Schilling
Head of the Department of Drug Design and Target Validation, Fraunhofer IZI

David Schmitt
Head of Product Development - BioProduct Delivery division - Europe, Catalent Biologics, Catalent Pharma Solutions

Sebastian Schuck
Global Director Business Development, Wacker Biotech GmbH

Evonne Sepsis
Founder and Managing Director, ESC Advisors

Florian Settele
Head of Business Unit Precision Capturing, Navigo Proteins GmbH

Sander Slootweg
Managing Partner, Forbion

Charlotte Smerdon
Cell & Gene Centre of Excellence Lead, Portfolio Director Project Management, Veristat

Catello Somma
Associate, TVM Life Science Management GmbH

Kerstin Stangier
Senior Director Global Integrations, Azenta / GENEWIZ

Katja Stout
Managing Director, Scius Communications

Michael Taeger
CEO, BMD Life Sciences GmbH

Hidetoshi Tahara
Vice President, Hiroshima University

Dorit Teichmann
Project Manager SaxoCell, Technische Universität Dresden

Michael Thompson
CEO, DyNAbind GmbH

Thomas Tradler
Head of Business Development and Patent Management, Fraunhofer IZI

Sandy Tretbar
Group Leader, Fraunhofer Institute for Cell Therapy and Immunology (IZI)

Yoshiaki Tsukamoto
Executive Director, Japan Bioindustry Association (JBA)

Felice Verduyn-van Weegen
Partner, EQT group

Ulrike Weirauch
Senior Scientist, Biomarker Center at the Fraunhofer Institute for Cell Therapy and Immunology

Alexandra Wollersheim
Partner, Alira Health

Roberto Zanchi
Head of Business Development and Commercialisation, Quadram Institute Bioscience

Keely Zipp
Founder, Stark Strategic Advisors

2022 Sponsors and Partners

REGIONAL HOST:
• biosaxony

PLATINUM SPONSORS:
• Amgen
• Bayer
• Bio Connection
• BioWin
• Boehringer Ingelheim
• Bristol Myers Squibb
• Caregen
• Dentons
• IPSEN
• Jetro
• KHIDI
• Lilly
• Lisa Life Science Austria
• Lisa Vienna
• Merck
• MSD
• Novartis Global Biotech Cooperations
• Rentschler Biopharma
• Roche
• Sachsen-Anhalt Investment and Marketing Corporation
• Wallonia.be

GOLD SPONSORS:
• AGC Biologics
• Almirall
• Alpha Sense
• Arriello
• Bio-M
• Catalent Biologics
• CG Pharma Biotech
• Citeline
• Dechert
• DNAQOR
• Eversana
• Evotec
• Ferring Pharmaceuticals
• Icon
• Lonza
• Nanoform
• Novartis
• Novo Nordisk
• Pfizer
• ProBioGen
• Richter-Helm
• SGS
• Single Use Support Pioneering BioPharma
• Sterling
• Veristat
• Vetter
• WuXi AppTec

SILVER SPONSORS:
• Ab Cellera
• Asahi KASEI
• BioAge
• Celonic
• ESC Advisors
• Evolution Life Science Partners
• Fujifilm | Diosynth biotechnologies
• GenScript Probio
• IDT Biologika
• Gradiant Bioconvergence
• Johnson and Johnson Innovation
• Life Sciences Acceleration Alliance
• MIG Capital
• Minaris Regenerative Medicine
• Organon
• Sanofi
• TVM Capital Life Science Venture Capital

MAIN MEDIA PARTNERS:
• BioCentury
• Biopharma Dealmakers
• EBR

MEDIA PARTNERS:
• BioCom
• Venture Valuation | Biotech Gate
• FreeMind
• GBI
• IITO
• Inova
• LSE
• LSG
• Lingmed
• MC Services
• MedNous
• Pharma Network Magazine
• SCIUS Communications
• Springer Nature

SUPPORTERS:
• ASE BIO
• Federchimica Assobiotec
• BIA
• Bio Deutschland
• BioNow
• Bio Partner
• BioteCanada
• BusinessFrance
• Business Region Goteborg
• Innovations Zentren
• Copenhagen Capacity
• Dansk Biotek
• FIB
• Flanders.bio
• Holland Bio
• ICPA
• Invest in Skane
• JBA
• Life Sciences Queensland
• MabDesign
• MediWales
• MSQ Ventures
• OBN
• One Nucleus
• Star Tree Ventures
• Sweden Bio
• Swiss Biotech
• Bio Taiwan
• U.S. Commercial Service